Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+8.75%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$38.8B
AUM Growth
-$1.01B
(-2.5%)
Cap. Flow
-$4.03B
Cap. Flow
% of AUM
-10.37%
Top 10 Holdings %
Top 10 Hldgs %
10.84%
Holding
3,658
New
595
Increased
588
Reduced
695
Closed
822
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$311M |
| 2 |
Biogen
BIIB
|
+$303M |
| 3 |
Nike
NKE
|
+$268M |
| 4 |
Alibaba
BABA
|
+$261M |
| 5 |
Citigroup
C
|
+$252M |
Top Sells
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$319M |
| 3 |
JPMorgan Chase
JPM
|
+$301M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$232M |
| 5 |
Boston Scientific
BSX
|
+$197M |
Sector Composition
| 1 | Financials | 17.87% |
| 2 | Healthcare | 17.83% |
| 3 | Technology | 16.43% |
| 4 | Consumer Discretionary | 15.13% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Morningstar
MORN
$10.8B
| $480K | ﹤0.01% |
2,218
+359
| +19% | +$77.8K |
|
|
RTL
1802
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $479K | ﹤0.01% |
+80,784
| New | +$479K |
|
1803
FS KKR Capital
FSK
$4.91B
| $475K | ﹤0.01% |
+27,169
| New | +$475K |
|
1804
LSI Industries
LYTS
$674M
| $474K | ﹤0.01% |
38,753
-11,812
| -23% | -$145K |
|
1805
SoundThinking
SSTI
$160M
| $472K | ﹤0.01% |
13,954
+4,432
| +47% | +$150K |
|
1806
PDS Biotechnology
PDSB
$54.5M
| $470K | ﹤0.01% |
35,632
+8,034
| +29% | +$106K |
|
|
ALLK
1807
DELISTED
Allakos
ALLK
| $470K | ﹤0.01% |
+55,782
| New | +$470K |
|
1808
Anika Therapeutics
ANIK
$125M
| $469K | ﹤0.01% |
+15,845
| New | +$469K |
|
|
YALA
1809
Yalla Group
YALA
$1.18B
| $468K | ﹤0.01% |
133,694
-87,828
| -40% | -$307K |
|
1810
HCI Group
HCI
$2.34B
| $467K | ﹤0.01% |
11,785
-37,314
| -76% | -$1.48M |
|
|
TETE
1811
DELISTED
Technology & Telecommunication Acquisition Corporation Class A Ordinary Shares
TETE
| $465K | ﹤0.01% |
45,200
| – | – |
|
|
LUNA
1812
DELISTED
Luna Innovations Incorporated
LUNA
| $463K | ﹤0.01% |
+52,628
| New | +$463K |
|
1813
AppFolio
APPF
$9.9B
| $458K | ﹤0.01% |
+4,342
| New | +$458K |
|
1814
Manchester United
MANU
$2.8B
| $457K | ﹤0.01% |
19,600
-19,300
| -50% | -$450K |
|
1815
MGP Ingredients
MGPI
$596M
| $454K | ﹤0.01% |
4,267
-5,710
| -57% | -$607K |
|
|
CUTR
1816
DELISTED
Cutera, Inc.
CUTR
| $454K | ﹤0.01% |
10,261
-2,639
| -20% | -$117K |
|
1817
Oramed Pharmaceuticals
ORMP
$98.8M
| $450K | ﹤0.01% |
37,399
+8,990
| +32% | +$108K |
|
1818
iShares US Pharmaceuticals ETF
IHE
$578M
| $448K | ﹤0.01% |
7,218
-1,200
| -14% | -$74.5K |
|
1819
Texas Pacific Land
TPL
$21.5B
| $448K | ﹤0.01% |
573
-1,557
| -73% | -$1.22M |
|
1820
Estee Lauder
EL
$30.1B
| $447K | ﹤0.01% |
1,800
-367,218
| -100% | -$91.1M |
|
|
EGRX
1821
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $447K | ﹤0.01% |
+15,276
| New | +$447K |
|
1822
First Internet Bancorp
INBK
$212M
| $446K | ﹤0.01% |
+18,356
| New | +$446K |
|
1823
Air Lease Corp
AL
$7.1B
| $445K | ﹤0.01% |
+11,590
| New | +$445K |
|
1824
Teva Pharmaceuticals
TEVA
$22.9B
| $445K | ﹤0.01% |
48,771
+1,273
| +3% | +$11.6K |
|
1825
PureCycle Technologies
PCT
$2.4B
| $444K | ﹤0.01% |
65,700
-1,030,012
| -94% | -$6.96M |
|